The University of Oxford It is said that it is creating a new cancer vaccine that can prevent dreaded disease before achieving it. Being developed with Pharmaceutical giant GSKJAB will target cells at the stage of the pre-cancer, which means that it will have the ability to prevent the disease from developing anytime.

“We can now really be able to detect undesirable,” said Professor Sarah Blogden of Oxford University. Cancerous immunological programPro. According to Blagden, the vaccine will be able to prevent cancer cells, before the disease catches and will wreak havoc on your body.

“Cancer does not come from anywhere. You always imagine that it will take about one or two years to develop in your body, but in fact, we now know that cancer can take up to 20 years, sometimes more, to develop to develop – To become cancer as a common cell infection, “he said on the Today’s Today’s Today’s Today.

“We know that in fact, at that point, Most cancers are invisible When they are passing by this, now we call the pre-cancer phase. And so the purpose of the vaccine is not to vaccinate against the established cans, but actually vaccination against that pre-cancer phase. ,

How the vaccine is being developed,

The program has been launched behind many technical and scientific progresses, which have made the capacity of vaccines against pre-cancer.

According to Professor Blagden, experts have identified what are the features of pre-cancer cells because they infection towards cancer-and therefore a vaccine can be specially designed to targeting. “In this case, we are actually going for cancer, but going on it at the pre-cancer phase,” he said.

Whereas vaccines that can prevent the disease from returning or even before mutated, the new vaccine intends to stop it before stopping the disease.

The program comes after the establishment of a molecular and computational medical institution to carry forward the research and development of new drugs in 2021 after GSK and Oxford. As part of the deal, GSK will invest up to £ 50 million in three years, which will be in pregorm, which will see how to identify weaknesses in pre-cancer cells with vaccine or targeted drug.

In 2023, in 2020, there were about 20 million new cases and 9.7 million cancer related deaths worldwide compared to 10 million. It is estimated that the lungs, bowel, liver and stomach are the most common causes of cancer death globally.

Now get the latest news with health and braking news and top headlines worldwide.